Top

Published in:

01-03-2018 | ORIGINAL ARTICLE

Overexpression of SIRT2 Alleviates Neuropathic Pain and Neuroinflammation Through Deacetylation of Transcription Factor Nuclear Factor-Kappa B

Authors: Yong Zhang, Dachao Chi

Published in: Inflammation | Issue 2/2018

Abstract

Sirtuin 2 (SIRT2), a member of the mammalian sirtuin family, plays an important role in the pathogenesis of various neurological diseases. However, whether SIRT2 is involved in the regulation of neuropathic pain remains unclear. In this study, we aimed to investigate the potential role of SIRT2 in regulating neuropathic pain in a rat model induced by chronic constriction injury (CCI). We found that SIRT2 was downregulated in the dorsal root ganglion (DRG) in CCI rats. Intrathecal injection of a recombinant adenovirus expressing SIRT2 markedly alleviated mechanical allodynia and thermal hyperalgesia in CCI rats. This also inhibited the expression of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 in the DRG of CCI rats. Moreover, our results showed that overexpression of SIRT2 inhibited the acetylation of the nuclear factor-kappa B (NF-κB) p65 protein in the DRG of CCI rats. Additionally, treatment with a SIRT2 specific inhibitor significantly aggravated neuropathic pain and attenuated the inhibitory effect of SIRT2 overexpression on neuropathic pain development. Taken together, these results suggest that overexpression of SIRT2 alleviates neuropathic pain associated with inhibition of NF-κB signaling and neuroinflammation. Therefore, SIRT2 may serve as a potential therapeutic target for treatment of neuropathic pain.

Baron, R. 2000. Peripheral neuropathic pain: from mechanisms to symptoms. The Clinical Journal of Pain 16: S12–S20. https://doi.org/10.1097/00002508-200006001-00004.CrossRefPubMed

Sorge, R.E., T. Trang, R. Dorfman, S.B. Smith, S. Beggs, J. Ritchie, J.S. Austin, D.V. Zaykin, H. Vander Meulen, M. Costigan, et al. 2012. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nature Medicine 18: 595–599. https://doi.org/10.1038/nm.2710.CrossRefPubMedCentralPubMed

Breivik, H., B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher. 2006. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain 10: 287–333. https://doi.org/10.1016/j.ejpain.2005.06.009.CrossRefPubMed

Bouhassira, D., M. Lanteri-Minet, N. Attal, B. Laurent, and C. Touboul. 2008. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136: 380–387. https://doi.org/10.1016/j.pain.2007.08.013.CrossRefPubMed

O'Connor, A.B., and R.H. Dworkin. 2009. Treatment of neuropathic pain: an overview of recent guidelines. The American Journal of Medicine 122: S22–S32. https://doi.org/10.1016/j.amjmed.2009.04.007.CrossRefPubMed

Myers, R.R., W.M. Campana, and V.I. Shubayev. 2006. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discovery Today 11: 8–20. https://doi.org/10.1016/S1359-6446(05)03637-8.CrossRefPubMed

Scholz, J., and C.J. Woolf. 2007. The neuropathic pain triad: neurons, immune cells and glia. Nature Neuroscience 10: 1361–1368. https://doi.org/10.1038/nn1992.CrossRefPubMed

Moalem, G., and D.J. Tracey. 2006. Immune and inflammatory mechanisms in neuropathic pain. Brain Research Reviews 51: 240–264. https://doi.org/10.1016/j.brainresrev.2005.11.004.CrossRefPubMed

Sun, T., W.G. Song, Z.J. Fu, Z.H. Liu, Y.M. Liu, and S.L. Yao. 2006. Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. British Journal of Anaesthesia 97: 553–558. https://doi.org/10.1093/bja/ael209.CrossRefPubMed

10.

Houtkooper, R.H., E. Pirinen, and J. Auwerx. 2012. Sirtuins as regulators of metabolism and healthspan. Nature Reviews Molecular Cell Biology 13: 225–238. https://doi.org/10.1038/nrm3293.CrossRefPubMedCentralPubMed

11.

Inoue, T., M. Hiratsuka, M. Osaki, and M. Oshimura. 2007. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 6: 1011–1018.CrossRefPubMed

12.

Harting, K., and B. Knoll. 2010. SIRT2-mediated protein deacetylation: an emerging key regulator in brain physiology and pathology. European Journal of Cell Biology 89: 262–269. https://doi.org/10.1016/j.ejcb.2009.11.006.CrossRefPubMed

13.

Cha, Y.I., and H.S. Kim. 2013. Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer. BMB Reports 46: 429–438. https://doi.org/10.5483/BMBRep.2013.46.9.180.CrossRefPubMedCentralPubMed

14.

Buechler, N., X. Wang, B.K. Yoza, C.E. McCall, and V. Vachharajani. 2017. Sirtuin 2 regulates microvascular inflammation during sepsis. Journal of Immunology Research 2017: 2648946. https://doi.org/10.1155/2017/2648946.CrossRefPubMedCentralPubMed

15.

Starke, R.M., R.J. Komotar, and E.S. Connolly. 2013. The role of SIRT2 in programmed necrosis: implications for stroke and neurodegenerative disorders. Neurosurgery 72: N20–N22. https://doi.org/10.1227/01.neu.0000430740.01610.74.CrossRef

16.

Wang, Y., Y. Mu, X. Zhou, H. Ji, X. Gao, W.W. Cai, Q. Guan, and T. Xu. 2017. SIRT2-mediated FOXO3a deacetylation drives its nuclear translocation triggering FasL-induced cell apoptosis during renal ischemia reperfusion. Apoptosis 22: 519–530. https://doi.org/10.1007/s10495-016-1341-3.CrossRefPubMed

17.

Zhao, Y., J. Yang, W. Liao, X. Liu, H. Zhang, S. Wang, D. Wang, J. Feng, L. Yu, and W.G. Zhu. 2010. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nature Cell Biology 12: 665–675. https://doi.org/10.1038/ncb2069.CrossRefPubMed

18.

Hoffmann, G., F. Breitenbucher, M. Schuler, and A.E. Ehrenhofer-Murray. 2014. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer. Journal of Biological Chemistry 289: 5208–5216. https://doi.org/10.1074/jbc.M113.487736.CrossRefPubMed

19.

Rothgiesser, K.M., S. Erener, S. Waibel, B. Luscher, and M.O. Hottiger. 2010. SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310. Journal of Cell Science 123: 4251–4258. https://doi.org/10.1242/jcs.073783.CrossRefPubMed

20.

Pais, T.F., E.M. Szego, O. Marques, L. Miller-Fleming, P. Antas, P. Guerreiro, R.M. de Oliveira, B. Kasapoglu, and T.F. Outeiro. 2013. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. The EMBO Journal 32: 2603–2616. https://doi.org/10.1038/emboj.2013.200.CrossRefPubMedCentralPubMed

21.

Yuan, F., Z.M. Xu, L.Y. Lu, H. Nie, J. Ding, W.H. Ying, and H.L. Tian. 2016. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-kappaB p65 acetylation and activation. Journal of Neurochemistry 136: 581–593. https://doi.org/10.1111/jnc.13423.CrossRefPubMed

22.

Yu, J., Y. Wu, and P. Yang. 2016. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects. Journal of Neurochemistry 137: 371–383. https://doi.org/10.1111/jnc.13587.CrossRefPubMedCentralPubMed

23.

Bennett, G.J., and Y.K. Xie. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87–107. https://doi.org/10.1016/0304-3959(88)90209-6.CrossRefPubMed

24.

Yaksh, T.L., and T.A. Rudy. 1976. Chronic catheterization of the spinal subarachnoid space. Physiology & Behavior 17: 1031–1036. https://doi.org/10.1016/0031-9384(76)90029-9.CrossRef

25.

Outeiro, T.F., E. Kontopoulos, S.M. Altmann, I. Kufareva, K.E. Strathearn, A.M. Amore, C.B. Volk, M.M. Maxwell, J.C. Rochet, P.J. McLean, et al. 2007. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317: 516–519. https://doi.org/10.1126/science.1143780.CrossRefPubMed

26.

Wang, X., Q. Guan, M. Wang, L. Yang, J. Bai, Z. Yan, Y. Zhang, and Z. Liu. 2015. Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7. Drug Design Development and Therapy 9: 2553–2563.CrossRef

27.

Silva, D.F., A.R. Esteves, C.R. Oliveira, and S.M. Cardoso. 2017. Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer's-disease related pathology. Molecular Neurobiology 54: 4021–4040. https://doi.org/10.1007/s12035-016-9951-x.CrossRefPubMed

28.

Luthi-Carter, R., D.M. Taylor, J. Pallos, E. Lambert, A. Amore, A. Parker, H. Moffitt, D.L. Smith, H. Runne, O. Gokce, et al. 2010. SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 107: 7927–7932. https://doi.org/10.1073/pnas.1002924107.CrossRefPubMedCentralPubMed

29.

Erburu, M., I. Munoz-Cobo, T. Diaz-Perdigon, P. Mellini, T. Suzuki, E. Puerta, and R.M. Tordera. 2017. SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 117: 195–208. https://doi.org/10.1016/j.neuropharm.2017.01.033.CrossRefPubMed

30.

Liu, R., W. Dang, Y. Du, Q. Zhou, K. Jiao, and Z. Liu. 2015. SIRT2 is involved in the modulation of depressive behaviors. Scientific Reports 5: 8415.CrossRefPubMedCentralPubMed

31.

Xie, X.Q., P. Zhang, B. Tian, and X.Q. Chen. 2016. Downregulation of NAD-dependent deacetylase SIRT2 protects mouse brain against ischemic stroke. Molecular Neurobiology. https://doi.org/10.1093/biomet/asw035.

32.

Krey, L., F. Luhder, K. Kusch, B. Czech-Zechmeister, B. Konnecke, T. Fleming Outeiro, and G. Trendelenburg. 2015. Knockout of silent information regulator 2 (SIRT2) preserves neurological function after experimental stroke in mice. Journal of Cerebral Blood Flow and Metabolism 35: 2080–2088. https://doi.org/10.1038/jcbfm.2015.178.CrossRefPubMedCentralPubMed

33.

Wang, X., N.L. Buechler, A. Martin, J. Wells, B. Yoza, C.E. McCall, and V. Vachharajani. 2016. Sirtuin-2 regulates sepsis inflammation in ob/ob mice. PLoS One 11: e0160431. https://doi.org/10.1371/journal.pone.0169417.CrossRefPubMedCentralPubMed

34.

Lo, Sasso G., K.J. Menzies, A. Mottis, A. Piersigilli, A. Perino, H. Yamamoto, K. Schoonjans, and J. Auwerx. 2014. SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS One 9: e103573. https://doi.org/10.1371/journal.pone.0114617.CrossRef

35.

Lin, J., B. Sun, C. Jiang, H. Hong, and Y. Zheng. 2013. Sirt2 suppresses inflammatory responses in collagen-induced arthritis. Biochemical and Biophysical Research Communications 441: 897–903. https://doi.org/10.1016/j.bbrc.2013.10.153.CrossRefPubMed

36.

Chen, L., W. Fischle, E. Verdin, and W.C. Greene. 2001. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293: 1653–1657. https://doi.org/10.1126/science.1062374.CrossRef

37.

Kim, M.J., D.W. Kim, J.H. Park, S.J. Kim, C.H. Lee, J.I. Yong, E.J. Ryu, S.B. Cho, H.J. Yeo, J. Hyeon, et al. 2013. PEP-1-SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes in murine macrophages. Free Radical Biology and Medicine 63: 432–445. https://doi.org/10.1016/j.freeradbiomed.2013.06.005.CrossRefPubMed

38.

Lee, A.S., Y.J. Jung, D. Kim, T. Nguyen-Thanh, K.P. Kang, S. Lee, S.K. Park, and W. Kim. 2014. SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochemical and Biophysical Research Communications 450: 1363–1369. https://doi.org/10.1016/j.bbrc.2014.06.135.CrossRefPubMed

39.

Chen, H., D. Wu, X. Ding, and W. Ying. 2015. SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. Neuroreport 26: 88–93. https://doi.org/10.1097/WNR.0000000000000305.CrossRefPubMed

40.

Wang, B., Y. Zhang, W. Cao, X. Wei, J. Chen, and W. Ying. 2016. SIRT2 plays significant roles in lipopolysaccharides-induced neuroinflammation and brain injury in mice. Neurochemical Research 41: 2490–2500. https://doi.org/10.1007/s11064-016-1981-2.CrossRefPubMed

41.

Szego, E.M., E. Gerhardt, and T.F. Outeiro. 2017. Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3beta/beta-catenin pathway. Neurobiology of Aging 56: 7–16. https://doi.org/10.1016/j.neurobiolaging.2017.04.001.CrossRefPubMed

42.

Park, J.H., C.K. Kim, S.B. Lee, K.H. Lee, S.W. Cho, and J.Y. Ahn. 2016. Akt attenuates apoptotic death through phosphorylation of H2A under hydrogen peroxide-induced oxidative stress in PC12 cells and hippocampal neurons. Scientific Reports 6: 21857.CrossRefPubMedCentralPubMed

43.

Fu, Z., and J. Shi. 2017. Differential expression of tubulin acetylase and deacetylase between the damaged dentral and peripheral branch of dorsal root ganglion neurons. Medical Science Monitor 23: 3673–3678. 10.12659/MSM.902829.CrossRefPubMedCentralPubMed

44.

Valle, C., I. Salvatori, V. Gerbino, S. Rossi, L. Palamiuc, F. Rene, and M.T. Carri. 2014. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death & Disease 5: e1296. https://doi.org/10.1038/cddis.2014.247.CrossRef

45.

Maxwell, M.M., E.M. Tomkinson, J. Nobles, J.W. Wizeman, A.M. Amore, L. Quinti, V. Chopra, S.M. Hersch, and A.G. Kazantsev. 2011. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Human Molecular Genetics 20: 3986–3996. https://doi.org/10.1093/hmg/ddr326.CrossRefPubMedCentralPubMed

46.

Ma, B., J. Shi, L. Jia, W. Yuan, J. Wu, Z. Fu, Y. Wang, N. Liu, and Z. Guan. 2013. Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model. PLoS One 8: e56580. https://doi.org/10.1371/journal.pone.0084903.CrossRefPubMedCentralPubMed

Title: Overexpression of SIRT2 Alleviates Neuropathic Pain and Neuroinflammation Through Deacetylation of Transcription Factor Nuclear Factor-Kappa B
Authors: Yong Zhang
Dachao Chi
Publication date: 01-03-2018
Publisher: Springer US
Published in: Inflammation / Issue 2/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-017-0713-3

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Overexpression of SIRT2 Alleviates Neuropathic Pain and Neuroinflammation Through Deacetylation of Transcription Factor Nuclear Factor-Kappa B

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2018

MicroRNA-21-Mediated Inhibition of Mast Cell Degranulation Involved in the Protective Effect of Berberine on 2,4-Dinitrofluorobenzene-Induced Allergic Contact Dermatitis in Rats via p38 Pathway

PI3K Is a Linker Between L-selectin and PSGL-1 Signaling to IL-18 Transcriptional Activation at the Promoter Level

The Anti-inflammatory Effects of 4-((5-Bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic Acid in Lipopolysaccharide-Activated Primary Microglial Cells

Changes in Neutrophil Metabolism upon Activation and Aging

High Glucose Stimulates Expression of MFHAS1 to Mitigate Inflammation via Akt/HO-1 Pathway in Human Umbilical Vein Endothelial Cells

Cardioprotective Effects of Morroniside in Rats Following Acute Myocardial Infarction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page